Study S000111

Evaluation of Circulating Endothelial Inflammatory Biomarkers in Response to GLP-1 Agonist Semaglutide in Acute Pulmonary Embolism

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06118203
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 18
Start: 2022-01-02
Primary completion: 2023-03-04
Lead sponsor: Imperial College London
Conditions: Pulmonary Embolism
Interventions: DRUG:Semaglutide
Results posted: FALSE

Registered primary outcomes

Endothelial biomarker measurement [4 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0006883	GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profiling. Samaranayake CB, European heart journal open	2026	Randomized trial	PMID 41536961 DOI	cites ClinicalTrials.gov:NCT06118203; registry reference DERIVED:41536961